Saravanan Yuvaraj

1.1k total citations · 1 hit paper
16 papers, 807 citations indexed

About

Saravanan Yuvaraj is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Saravanan Yuvaraj has authored 16 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Saravanan Yuvaraj's work include Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Cell death mechanisms and regulation (4 papers). Saravanan Yuvaraj is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Cell death mechanisms and regulation (4 papers). Saravanan Yuvaraj collaborates with scholars based in Netherlands, United States and Norway. Saravanan Yuvaraj's co-authors include Rudi W. Hendriks, Laurens P. Kil, Maikel P. Peppelenbosch, Nicolaas A. Bos, Frank A.E. Kruyt, Godefridus J. Peters, Kaamar Azijli, Anton W. Langerak, Carmen Verı́ssima Ferreira and Steven de Jong and has published in prestigious journals such as Nature reviews. Cancer, The Journal of Immunology and Journal of Cell Science.

In The Last Decade

Saravanan Yuvaraj

15 papers receiving 795 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Bruton's tyrosine kinase in B cell malignancies

2014 399 citations Rudi W. Hendriks, Saravanan Yuvaraj et al. Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Saravanan Yuvaraj

Since Specialization

Citations

This map shows the geographic impact of Saravanan Yuvaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saravanan Yuvaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saravanan Yuvaraj more than expected).

Fields of papers citing papers by Saravanan Yuvaraj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saravanan Yuvaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saravanan Yuvaraj. The network helps show where Saravanan Yuvaraj may publish in the future.

Co-authorship network of co-authors of Saravanan Yuvaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Saravanan Yuvaraj. A scholar is included among the top collaborators of Saravanan Yuvaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saravanan Yuvaraj. Saravanan Yuvaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Macrophages orchestrate elimination of Shigella from the intestinal epithelial cell niche via TLR-induced IL-12 and IFN-γ 2025 ·Cell Host & Microbe ·(unknown), Christine Nichols, (unknown), Saravanan Yuvaraj, (unknown), Justin L. Roncaioli, (unknown), Gregory M. Barton, Cammie F. Lesser, Russell E. Vance	0
2	The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma 2014 ·SpringerPlus ·(unknown), Carlos R. Reis, Rita Setroikromo, Saravanan Yuvaraj, Justin V. Joseph, Pieter G. Tepper, Frank A.E. Kruyt, Wim J. Quax	13
3	Targeting Bruton's tyrosine kinase in B cell malignancies breakdown → 2014 ·Nature reviews. Cancer ·Rudi W. Hendriks, Saravanan Yuvaraj, Laurens P. Kil	399
4	Pre-B Cell Receptor Signaling Induces Immunoglobulin κ Locus Accessibility by Functional Redistribution of Enhancer-Mediated Chromatin Interactions 2014 ·PLoS Biology ·Ralph Stadhouders, Marjolein J. W. de Bruijn, Magdalena B. Rother, Saravanan Yuvaraj, Claudia Ribeiro de Almeida, Petros Kolovos, Menno C. van Zelm, Wilfred F. J. van IJcken, Frank Grosveld, Éric Soler, Rudi W. Hendriks	42
5	MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1 2013 ·APOPTOSIS ·Kaamar Azijli, Saravanan Yuvaraj, (unknown), Koen D. Flach, Elisa Giovannetti, Godefridus J. Peters, Steven de Jong, Frank A.E. Kruyt	38
6	Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia. 2013 ·PubMed ·Laurens P. Kil, (unknown), (unknown), Anton W. Langerak, Saravanan Yuvaraj, Rudi W. Hendriks	47
7	BLNK (B-cell linker) 2013 ·Atlas of Genetics and Cytogenetics in Oncology and Haematology ·Saravanan Yuvaraj, (unknown)	1
8	Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells 2012 ·Journal of Cell Science ·Kaamar Azijli, Saravanan Yuvaraj, Maikel P. Peppelenbosch, Thomas Würdinger, Henk Dekker, Jos Joore, (unknown), Wim J. Quax, Godefridus J. Peters, Steven de Jong, Frank A.E. Kruyt	59
9	The Role of B Cell Receptor Stimulation in CLL Pathogenesis 2012 ·Current Pharmaceutical Design ·Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak, Rudi W. Hendriks	11
10	Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy 2012 ·Annals of the Rheumatic Diseases ·(unknown), Hendrika Bootsma, Saravanan Yuvaraj, Fred K. L. Spijkervet, Erlin A. Haacke, Rodney Pollard, Annie Visser, Arjan Vissink, Cees G. M. Kallenberg, Frans G. M. Kroese, Nicolaas A. Bos	47
11	E. coli-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study 2012 ·Gastroenterology Research and Practice ·Saravanan Yuvaraj, Saad Al-Lahham, Rajesh Somasundaram, (unknown), Maikel P. Peppelenbosch, Nicolaas A. Bos	16
12	TRAIL-induced pro- and anti-apoptotic kinase activation in Non small cell lung cancer cells 2012 ·Data Archiving and Networked Services (DANS) ·Kaamar Azijli, Jos Joore, Saravanan Yuvaraj, Maikel P. Peppelenbosch, Thomas Würdinger, Henk Dekker, Erwin van Dijk, Wim J. Quax, Godefridus J. Peters, (unknown), Frank A.E. Kruyt	18
13	Evidence for Local Expansion of IgA Plasma Cell Precursors in Human Ileum 2009 ·The Journal of Immunology ·Saravanan Yuvaraj, Gerard Dijkstra, Johannes G. M. Burgerhof, Peter M. Dammers, Maaike Stoel, Annie Visser, Frans G. M. Kroese, Nicolaas A. Bos	29
14	Modulation of Src Activity by Low Molecular Weight Protein Tyrosine Phosphatase During Osteoblast Differentiation 2008 ·Cellular Physiology and Biochemistry ·Willian Fernando Zambuzzi, José Mauro Granjeiro, Kaushal Parikh, Saravanan Yuvaraj, Maikel P. Peppelenbosch, Carmen Verı́ssima Ferreira	61
15	Human scFv SIgA expressed on Lactococcus lactis as a vector for the treatment of mucosal disease 2008 ·Molecular Nutrition & Food Research ·Saravanan Yuvaraj, (unknown), Ravi K. R. Marreddy, Gerard Dijkstra, Wout A. M. Wolken, Juke S. Lolkema, Wijnand Helfrich, (unknown), Maikel P. Peppelenbosch, Nicolaas A. Bos	8
16	Early bacterial dependent induction of inducible nitric oxide synthase (iNOS) in epithelial cells upon transfer of CD45RBhigh CD4+ T cells in a model for experimental colitis 2007 ·Inflammatory Bowel Diseases ·Gerard Dijkstra, Saravanan Yuvaraj, Han-Qing Jiang, (unknown), Han Moshage, Natasha Kushnir, Maikel P. Peppelenbosch, John J. Cebra, Nicolaas A. Bos	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact